Latest Asx News

Global X Management (AUS) Limited has announced final distribution amounts for 28 ETFs listed on the ASX AQUA Market, revealing a varied payout landscape for the period ending 31 December 2025.

Auris Minerals Limited has been queried by the ASX following a sharp rise in its share price and trading volume, with the company denying any undisclosed information behind the surge.

Medallion Metals Limited has opened a Share Purchase Plan offering eligible shareholders in Australia and New Zealand the chance to buy shares at a 20.8% discount, aiming to raise $5 million for advancing its Forrestania and Cosmic Boy projects.

Embark Early Education Limited has initiated an off-market takeover bid for Mayfield Childcare Limited, offering shareholders a choice between scrip or cash consideration at a significant premium. The bid aims to consolidate operations and expand Embark’s footprint across Australia’s childcare sector.

Estrella Resources appoints Robert Mencel as CEO, transitioning to Managing Director by mid-2026, to spearhead its limestone and manganese projects in Timor-Leste. The leadership reshuffle aims to accelerate development and operational ramp-up.

Carbonxt Group Limited has raised $600,000 through a share placement to fund working capital and increase its ownership in New Carbon Processing, LLC to 46.7%. The move supports progress at New Carbon’s Kentucky facility as it nears commissioning.

TMK Energy has achieved a fifth consecutive month of rising gas production at its Gurvantes XXXV Project in Mongolia, hitting a new daily record in December 2025. The company is now advancing plans to harness this gas for power generation, signalling a promising commercial phase ahead.

Verity Resources has secured a major new exploration licence at its Monument Gold Project in Western Australia, doubling its landholding to over 400 square kilometres and unlocking fresh exploration opportunities in the prolific Laverton Goldfields.

Asara Resources has released a second tranche of drilling results from its Massan deposit in Guinea, reinforcing the continuity of gold mineralisation and confirming promising depth extensions beyond the current resource model.

BlinkLab Limited has secured independent scientific validation for its smartphone-based autism diagnostic technology through publication in the prestigious journal Autism Research, marking a significant milestone ahead of its FDA regulatory trial.

Island Pharmaceuticals reports ongoing FDA review of its antiviral Galidesivir, with no adverse feedback received as the regulator takes extra time to finalise guidance.

Biome Australia Limited has reported a record-breaking quarter and half-year sales performance, driven by strong demand for its clinically-backed probiotic products. Revenue surged over 40% compared to the previous year, defying typical seasonal slowdowns.